Cargando…
Therapy-Associated Myeloid Dysplasia in a Long-Surviving Patient with Pancreatic Cancer
Pancreatic cancer remains a diagnosis of poor prognosis with a median survival time of four-six months in patients with advanced stage of the disease. Although, with the development of novel chemotherapy agents some patients are able to live a little longer if they respond to therapy. However, long-...
Autores principales: | Suzukida, Jillian, Kaley, Kristin, Raza, Azra, Saif, Muhammad W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981410/ https://www.ncbi.nlm.nih.gov/pubmed/27555985 http://dx.doi.org/10.7759/cureus.687 |
Ejemplares similares
-
The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy
por: Waters, Michael R, et al.
Publicado: (2023) -
Boron Neutron Capture Therapy for Recurrent Glioblastoma Multiforme: Imaging Evaluation of a Case With Long-Term Local Control and Survival
por: Shimizu, Shosei, et al.
Publicado: (2023) -
Dosimetric Comparison of Whole Breast Radiotherapy Using Field-in-Field and Volumetric Modulated Arc Therapy Techniques in Left-Sided Breast Cancer Patients
por: Waheed, Asmara, et al.
Publicado: (2021) -
Pancreatic Adenocarcinoma Complicated by Sinistral Portal Hypertension
por: Saif, Muhammad W, et al.
Publicado: (2016) -
Long-Term Survival After Repeated Salvage Chemoradiation Therapy for Metastatic Lymph Node Recurrence in Advanced Gastric Cancer: A Case Report
por: Katano, Atsuto, et al.
Publicado: (2023)